Identifying areas in California with high opioid overdoses and limited treatment access
Examining patterns of opioid overdose hotspots and opioid treatment deserts in California
This study looks at where opioid overdoses happen most often in California and where treatment options are hard to find, so we can help public health officials better support people struggling with opioid use disorder.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11055993 on NIH RePORTER |
What this research studies
This research investigates the patterns of opioid overdose incidents and the availability of treatment options in California. By analyzing emergency medical services data and treatment center locations, the study aims to identify 'hotspots' where overdoses are frequent and 'treatment deserts' where access to care is limited. The research employs advanced statistical modeling and qualitative methods to provide insights that can help public health officials target interventions effectively. The goal is to enhance understanding of the local factors contributing to opioid use disorder and improve access to necessary treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in California who are affected by opioid use disorder or are at risk of overdose.
Not a fit: Patients who do not reside in California or who are not impacted by opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for addressing opioid overdoses and enhancing access to treatment for affected populations.
How similar studies have performed: Previous research has shown success in using similar data-driven approaches to identify health disparities and inform public health interventions.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Jaros, Samuel — Stanford University
- Study coordinator: Jaros, Samuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.